Immunic Inc. (NASDAQ: IMUX) is -85.79% lower on its value in year-to-date trading and has touched a low of $1.31 and a high of $14.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IMUX stock was last observed hovering at around $1.31 in the last trading session, with the day’s gains setting it 0.05% off its average median price target of $15.00 for the next 12 months. It is also 96.51% off the consensus price target high of $39.00 offered by 5 analysts, but current levels are 72.8% higher than the price target low of $5.00 for the same period.
Currently trading at $1.36, the stock is -12.71% and -62.98% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.08 million and changing 3.82% at the moment leaves the stock -78.02% off its SMA200. IMUX registered -84.99% loss for a year compared to 6-month loss of -77.33%.
The stock witnessed a -20.00% gain in the last 1 month and extending the period to 3 months gives it a -73.64%, and is -4.23% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.80% over the week and 9.55% over the month.
Distance from 52-week low is 3.82% and -90.62% from its 52-week high.
Immunic Inc. (IMUX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Immunic Inc. (IMUX) is a “Buy”. 5 analysts offering their recommendations for the stock have an average rating of 1.80, where 1 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Immunic Inc. is expected to release its quarterly report on 02/24/2023.The EPS is expected to shrink by -39.80% this year
Immunic Inc. (IMUX) Top Institutional Holders
The shares outstanding are 39.26M, and float is at 33.96M with Short Float at 20.77%.
Immunic Inc. (IMUX) Insider Activity
A total of 2 insider transactions have happened at Immunic Inc. (IMUX) in the last six months, with sales accounting for 0 and purchases happening 2 times. The most recent transaction is an insider purchase by Vitt Daniel, the company’s President and CEO. SEC filings show that Vitt Daniel bought 8,000 shares of the company’s common stock on Nov 22 at a price of $1.35 per share for a total of $10799.0. Following the purchase, the insider now owns 0.38 million shares.
Immunic Inc. disclosed in a document filed with the SEC on Nov 07 that Whaley Glenn (Chief Financial Officer) bought a total of 5,000 shares of the company’s common stock. The trade occurred on Nov 07 and was made at $1.50 per share for $7475.0. Following the transaction, the insider now directly holds 20510.0 shares of the IMUX stock.
Still, SEC filings show that on Jun 03, Vitt Daniel (President and CEO) acquired 5,000 shares at an average price of $3.10 for $15500.0. The insider now directly holds 368,877 shares of Immunic Inc. (IMUX).